IBD: Limited Protection Against Omicron With Third Vaccine Dose IBD: Limited Protection Against Omicron With Third Vaccine Dose

Patients with IBD taking infliximab or tofacitinib may be more vulnerable to Omicron infection even after a third dose of a COVID-19 mRNA vaccine.MDedge News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news